Skip to main content

VEGAS 2025 SPEAKERS WL

HEADING

Loading

GLP-1’s Impact on Weight Loss Industry

16 Oct 2025
Theater 10 LV Sponsored by EFI
Though GLP-1 agonist drugs have been shown to be extremely effective for rapid weight loss, there are some cautionary effects that should not be overlooked.  As this application to the Diabetes drug has shifted toward weight loss, individuals that are focused on the scale should also focus on what can happen to their bodies.  This seminar will focus on the business impact on the wieght loss industry, and the physical impact to those using GLP-1 agonist drugs for cosmetic reasons.  There are products and lifestyle solutions to help those on a rapid weight loss journey with GLP-1, which will be presented at this seminar.
Speakers
Jim Ayres, CEO, Founder - Kelker Pharma, dba Nutrilinq

 

Pop up that states want to generate more leads at White Label World Expo 2026

 

 London